[Cannabinoids in multiple sclerosis -- therapeutically reasonable?]

Fortschr Neurol Psychiatr. 2005 Dec;73(12):713-4. doi: 10.1055/s-2005-870992.

[Article in German]

Author

E Mauch

PMID: 16355313
DOI: 10.1055/s-2005-870992

No abstract available

Publication types

Editorial

MeSH terms

Cannabinoids / adverse effects
Cannabinoids / therapeutic use*
Humans
Multiple Sclerosis / drug therapy*

Substances

Cannabinoids